GNPX Trade on Feb 26, 2020 10:10 from beno: Tradervue User Stock Trades.

Gravatar

Shared by
beno

 

Fundamentals

Shares Outstanding: 32.8m (latest)
Cash: 2.55m (+ $8m from Jan 28 offering, + $17.5m from Feb 19 offering)
Current liabilities: 537k
Current ratio: 6.72
NWC (total current assets - total current liabilities): 3.07m
Monthly Burn rate (net loss / months): 578k
Estimated current cash: 527k
Accumulated deficit: 38m
Book value (Stock holder equity / Shares outstanding): 0.223 (no longer accurate with new SO)

Catalysts / News / Painting the picture

-Receives FDA Fast track for its Oncorpex Immunogene therapy that targets lung cancer
-Sign Exclusive License Agreement with University of Pittsburgh for Potentially Curative Gene Therapy Candidate for Diabetes
-$25m shelf, recent offering 17/01/20 for $1.267m
-2020-01-28: Closes $8m offering
-2020-02-21: Closes $17.5m offering
-Enough cash for 43.5 months! Doesn't need to do another offering for awhile!

Technical Analysis

-no gap
-Weak open
-Faded all day
-Levels: 4.75, 5.50, 5.75

Original Plan / Strategy

First Test short of 5.50 with half dollar and VWAP confluence

Review

The 3 bars before the trade was sketchy / very grindy action littered with bid props, in hindsight it looks like the props were their to fill the sellers short orders. Only got one lot filled at 4.49 before it started tanking, didn't want to chase this down as SSR was on, took 20 cents of profit

image


Execution detail:

Date/time Symbol Side Price Position
2020-02-26 10:10:48 GNPX sell $5.490 short
2020-02-26 10:14:09 GNPX buy $5.310 0


Leave a comment about this trade!

You need to log into your Tradervue account to leave a comment. If you don't have one,
it takes just a few seconds to sign up, and it's free!

View plans, Sign up for free, or Log in